M.D. Holdom

1.1k total citations
17 papers, 842 citations indexed

About

M.D. Holdom is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, M.D. Holdom has authored 17 papers receiving a total of 842 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in M.D. Holdom's work include Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). M.D. Holdom is often cited by papers focused on Antifungal resistance and susceptibility (6 papers), Fungal Infections and Studies (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). M.D. Holdom collaborates with scholars based in United Kingdom, United States and Thailand. M.D. Holdom's co-authors include Andrew J. Hamilton, Barbara Léchenne, Michel Monod, Roderick J. Hay, Christophe Zaugg, Olivier Jousson, Andrew J. Beavil, Brian J. Sutton, Anna M. Davies and Enrico Girardi and has published in prestigious journals such as Chemical Communications, Scientific Reports and Biochemical Journal.

In The Last Decade

M.D. Holdom

17 papers receiving 819 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.D. Holdom United Kingdom 14 289 256 250 208 126 17 842
Veronica M. Hearn United Kingdom 20 544 1.9× 369 1.4× 371 1.5× 285 1.4× 57 0.5× 46 1.0k
Kuppamuthu Dharmalingam India 21 216 0.7× 559 2.2× 133 0.5× 106 0.5× 173 1.4× 78 1.2k
V. Chazalet France 15 291 1.0× 493 1.9× 179 0.7× 237 1.1× 181 1.4× 20 943
Paula Magnelli United States 18 235 0.8× 668 2.6× 182 0.7× 235 1.1× 161 1.3× 27 1.1k
Rémi Beau France 21 502 1.7× 537 2.1× 270 1.1× 381 1.8× 157 1.2× 41 1.1k
Muriel Bernard France 8 216 0.7× 271 1.1× 137 0.5× 217 1.0× 45 0.4× 9 565
Dorothy C. Young United States 17 303 1.0× 446 1.7× 191 0.8× 89 0.4× 33 0.3× 37 1.1k
Jean‐Paul Léonetti France 24 157 0.5× 936 3.7× 95 0.4× 49 0.2× 70 0.6× 41 1.3k
Jon P. Woods United States 21 444 1.5× 325 1.3× 640 2.6× 335 1.6× 74 0.6× 29 960
Gioacchino Micheli Italy 21 200 0.7× 871 3.4× 59 0.2× 155 0.7× 47 0.4× 33 1.4k

Countries citing papers authored by M.D. Holdom

Since Specialization
Citations

This map shows the geographic impact of M.D. Holdom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.D. Holdom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.D. Holdom more than expected).

Fields of papers citing papers by M.D. Holdom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.D. Holdom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.D. Holdom. The network helps show where M.D. Holdom may publish in the future.

Co-authorship network of co-authors of M.D. Holdom

This figure shows the co-authorship network connecting the top 25 collaborators of M.D. Holdom. A scholar is included among the top collaborators of M.D. Holdom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.D. Holdom. M.D. Holdom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ramadani, Faruk, Rebecca L. Beavil, M.D. Holdom, et al.. (2018). Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody. Scientific Reports. 8(1). 11548–11548. 22 indexed citations
2.
McKendrick, John E., M.D. Holdom, Birgit A. Helm, et al.. (2012). Synthesis and Incorporation into Cyclic Peptides of Tolan Amino Acids and Their Hydrogenated Congeners: Construction of an Array of A–B-loop Mimetics of the Cε3 Domain of Human IgE. The Journal of Organic Chemistry. 77(7). 3197–3214. 20 indexed citations
3.
Holdom, M.D., Anna M. Davies, Joanne E. Nettleship, et al.. (2011). Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI. Nature Structural & Molecular Biology. 18(5). 571–576. 102 indexed citations
4.
Saab, Fabienne, M.D. Holdom, Anna M. Davies, et al.. (2011). Synthesis of the C19 methyl ether of aspercyclide A via germyl-Stille macrocyclisation and ELISA evaluation of both enantiomers following optical resolution. Organic & Biomolecular Chemistry. 9(19). 6814–6814. 8 indexed citations
5.
Holdom, M.D., Philip Dusart, Andrew J. P. White, et al.. (2009). Total synthesis of (±)-aspercyclide A and its C19 methyl ether. Chemical Communications. 46(11). 1824–1826. 21 indexed citations
6.
Hamilton, Andrew J. & M.D. Holdom. (2008). Antioxidant systems in the pathogenic fungi of man and their role in virulence. Medical Mycology. 37(6). 375–389. 3 indexed citations
7.
Girardi, Enrico, M.D. Holdom, Anna M. Davies, Brian J. Sutton, & Andrew J. Beavil. (2008). The crystal structure of rabbit IgG-Fc. Biochemical Journal. 417(1). 77–83. 23 indexed citations
8.
Monod, Michel, et al.. (2002). Secreted proteases from pathogenic fungi. International Journal of Medical Microbiology. 292(5-6). 405–419. 279 indexed citations
9.
Verweij, Paul E., et al.. (2000). Clinical applications of non-culture based methods for the diagnosis and management of opportunistic and endemic mycoses. Medical Mycology. 38(s1). 161–171. 22 indexed citations
10.
Holdom, M.D., Barbara Léchenne, Roderick J. Hay, Andrew J. Hamilton, & Michel Monod. (2000). Production and Characterization of Recombinant Aspergillus fumigatus Cu,Zn Superoxide Dismutase and Its Recognition by Immune Human Sera. Journal of Clinical Microbiology. 38(2). 558–562. 51 indexed citations
11.
Hamilton, Andrew J. & M.D. Holdom. (1999). Antioxidant systems in the pathogenic fungi of man and their role in virulence. Medical Mycology. 37(6). 375–389. 88 indexed citations
12.
Hamilton, Andrew J. & M.D. Holdom. (1997). Biochemical comparison of the Cu,Zn superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii. Infection and Immunity. 65(2). 488–494. 34 indexed citations
13.
Ungpakorn, Rataporn, M.D. Holdom, Andrew J. Hamilton, & R. J. Hay. (1996). Purification and partial characterization of the Cu, Zn superoxide dismutase from the dermatophyteTrichophyton mentagrophytesvar.interdigitale. Clinical and Experimental Dermatology. 21(3). 190–196. 7 indexed citations
14.
Hamilton, Andrew J., et al.. (1996). Expression of the Cu,Zn superoxide dismutase ofAspergillus fumigatusas determined by immunochemistry and immunoelectron microscopy. FEMS Immunology & Medical Microbiology. 14(2-3). 95–102. 29 indexed citations
16.
Holdom, M.D., Roderick J. Hay, & Andrew J. Hamilton. (1995). Purification, N-Terminal Amino Acid Sequence and Partial Characterization of A Cu,Zn Superoxide Dismutase From the Pathogenic FungusAspergillusfumiga Tus. Free Radical Research. 22(6). 519–531. 36 indexed citations
17.
Hamilton, Andrew J., M.D. Holdom, & Roderick J. Hay. (1995). Specific recognition of purified Cu,Zn superoxide dismutase from Aspergillus fumigatus by immune human sera. Journal of Clinical Microbiology. 33(2). 495–496. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026